N-terminal pro B-type natriuretic peptide levels predict newly detected atrial fibrillation in a population-based cohort

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Netherlands Heart Journal

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF03086122PMID 18345329PMCID PMC2266866
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP.

  2007cited by this paper
• The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation.

  2006cited by this paper
• Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.

  2006cited by this paper
• Determinants of brain natriuretic peptide levels in patients with lone atrial fibrillation.

  2006cited by this paper
• Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation.

  2005cited by this paper
• C-reactive protein and microalbuminuria are associated with atrial fibrillation.

  2005cited by this paper
• Mild renal dysfunction is associated with electrocardiographic left ventricular hypertrophy.

  2005cited by this paper
• Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

  2005cited by this paper
• Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation.

  2004cited by this paper
• Plasma B-Type Natriuretic Peptide Levels Predict Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery

  2004cited by this paper
• Plasma natriuretic peptide levels and the risk of cardiovascular events and death.

  2004cited by this paper
• Inflammation as a Risk Factor for Atrial Fibrillation

  2003cited by this paper
• Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population.

  2003cited by this paper
• Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular Dysfunction Insight From the Studies Of Left Ventricular Dysfunction (SOLVD) Trials

  2003cited by this paper
• Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths.

  2002cited by this paper
• Plasma brain natriuretic peptide concentration: impact of age and gender.

  2002cited by this paper
• Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population

  2002cited by this paper
• Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women.

  2002cited by this paper
• Echocardiographic Left Ventricular Geometry in Hypertensive Patients with Electrocardiographic Left Ventricular Hypertrophy: The LIFE Study

  2001cited by this paper
• Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation.

  2000cited by this paper
• Prediction of paroxysmal atrial fibrillation in patients with congestive heart failure: a prospective study.

  2000cited by this paper
• Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patients with mild congestive heart failure.

  2000cited by this paper
• Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.

  1998cited by this paper
• Biochemical detection of left-ventricular systolic dysfunction.

  1998cited by this paper
• Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm.

  1998cited by this paper
• Histological substrate of atrial biopsies in patients with lone atrial fibrillation.

  1997cited by this paper
• Incidence of and risk factors for atrial fibrillation in older adults.

  1997cited by this paper
• Impact of Left Ventricular Structure on the Incidence of Hypertension: The Framingham Heart Study

  1994cited by this paper
• Methodology of the Modular ECG Analysis System MEANS

  1990cited by this paper

• The role of NT-proBNP in screening for atrial fibrillation in hypertensive disease

  2024cites this paper
• AI-enabled Left Atrial Volumetry in Cardiac CT Scans Improves CHARGE-AF and Outperforms NT-ProBNP for Prediction of Atrial Fibrillation in Asymptomatic Individuals: Multi-Ethnic Study of Atherosclerosis

  2024cites this paper
• AI-Enabled CT Cardiac Chamber Volumetry Predicts Atrial Fibrillation and Stroke Comparable to MRI

  2024cites this paper
• AI-enabled left atrial volumetry in coronary artery calcium scans (AI-CACTM) predicts atrial fibrillation as early as one year, improves CHARGE-AF, and outperforms NT-proBNP: The multi-ethnic study of atherosclerosis.

  2024cites this paper
• Biomarker-based prediction of sinus rhythm in atrial fibrillation patients: the EAST-AFNET 4 biomolecule study

  2024cites this paper
• Association between NT-proBNP levels and risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies

  2024cites this paper
• Nutritional Status as a Risk Factor for New-Onset Atrial Fibrillation in Acute Myocardial Infarction

  2023cites this paper
• Markers of Inflammation, Oxidative Stress, and Fibrosis in Patients with Atrial Fibrillation

  2022cites this paper
• Screening for precapillary pulmonary hypertension in chronic myeloproliferative disorders: the role of N-terminal pro-B-type natriuretic peptide and vascular endothelial growth factor – a pilot study

  2020cites this paper
• Serum N-terminal pro-B-type natriuretic peptide as a predictor for future development of atrial fibrillation in a general population: The Hisayama study.

  2020cites this paper
• Can the development of atrial fibrillation in patients with ischemic heart failure with low ejection fraction be predicted?

  2019cites this paper
• Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE).

  2018cites this paper
• Atrial Fibrillation and Anticoagulation in Hypertrophic Cardiomyopathy.

  2017cites this paper
• [Chronic kidney disease and atrial fibrillation as components of the cardiorenal continuum].

  2016cites this paper
• Acute atrial wall stretch and the efficacy of flecainide-induced conversion of atrial fibrillation

  2015influential citation
• Baseline NT-ProBNP level predicts success of cardioversion of atrial fibrillation with flecainide

  2015cites this paper
• Calcium channel blockers improve exercise capacity and reduce N-terminal ProB-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation

  2014cites this paper
• Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation.

  2014cites this paper
• BNP/NTPROBNP : Beyond Heart Failure

  2013cites this paper
• Natriuretic peptide levels predict recurrence of atrial fibrillation after radiofrequency catheter ablation.

  2011cites this paper
• A new tissue doppler index in predicting future atrial fibrillation in patients with heart failure.

  2011cites this paper
• Correlation between N-Terminal Pro-Brain Natriuretic Peptide and Doppler Echocardiographic Parameters of Left Ventricular Filling Pressure in Atrial Fibrillation

  2011cites this paper
• Predictive value of NT-proBNP for cardioversion in a new onset atrial fibrillation

  2011cites this paper
• Um novo índice de doppler tecidual para a predição de fibrilação atrial futura em pacientes com insuficiência cardíaca

  2011cites this paper
• Natriuretic peptides and atrial fibrillation.

  2010cites this paper
• Plasma renin activity and pro-B-type natriuretic peptide levels in different atrial fibrillation types.

  2010cites this paper
• Relations of Biomarkers of Distinct Pathophysiological Pathways and Atrial Fibrillation Incidence in the Community

  2010cites this paper
• Impact of atrial fibrillation on NT-proBNP levels in a 75-year-old population

  2009cites this paper
• Perindopril decreases P wave dispersion in patients with stage 1 hypertension

  2009influential citation
• N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation

  2009cites this paper
• A new predictor for the onset of atrial fibrillation?

  2008cites this paper